Federal News

Federal cannabis policy sits at the intersection of law enforcement, public health, banking regulation, and civil rights. Despite widespread legalization at the state level, cannabis remains classified under the federal Controlled Substances Act, creating a complex legal environment that affects every participant in the industry. Congressional action, DEA scheduling decisions, and executive orders all play critical roles in determining the future of cannabis in America.

The most closely watched federal developments include the ongoing rescheduling process, which could move cannabis from Schedule I to a lower classification, significantly reducing regulatory burdens and opening new avenues for medical research. Congressional bills such as banking reform proposals aim to give cannabis businesses access to traditional financial services, while broader legalization bills seek to end federal prohibition entirely. Each of these tracks proceeds through different agencies and legislative bodies, making it important to follow multiple threads simultaneously.

Leefii's federal news coverage provides clear, concise reporting on the actions of Congress, the DEA, the FDA, the Department of Justice, and the White House as they relate to cannabis policy. We track bill introductions, committee votes, floor debates, and final outcomes. We also cover federal enforcement trends, interstate commerce discussions, and the regulatory guidance that shapes how state-legal markets operate within the broader federal framework. Whether you are a business owner concerned about banking access, a patient awaiting expanded research, or a citizen following the legislative process, this section keeps you informed about the decisions that affect cannabis at the highest level of government.